Diligence memo · auto-generated · as of July 2, 2026
Transenterix Inc.
Transenterix Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Transenterix Inc. operates in Other Health Care, based in MORRISVILLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Transenterix Inc. has raised $210M in disclosed capital across 8 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $160M on 2013-09-03.
Most recent recorded round closed around 2017-09-12.
Valuation (modeled)modeled
Provath models Transenterix Inc. at approximately $22M (range $5.1M–$48M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.01× the median modeled value of Series D+ Other Health Care companies in 2016–2018 (7 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 13 months.
Last raise 8.8 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 8.2× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 98% of Other Health Care peers (5377 compared).
Modeled value ranks above 50% of those peers.
Closest niche peers: BNVC Group Holdings, Inc., Endologix Inc /De/, SYFS Intermediate Holdings, LLC, Allied Integral United, Inc., OneOncology Parent Holdings, LLC.
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.